Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Current Protocols in Molecular Biology|October 11, 2016
GILA, a Replacement for the Soft-Agar Assay that Permits High-Throughput Drug and Genetic Screens for Cellular TransformationBenjamin Izar, Asaf Rotem
Cancer Research|November 8, 2024
Peritumoral Venous Vessels: Autobahn and Portal for T Cells to Melanoma Brain MetastasisBenjamin Izar, Minah Kim
International Journal of Molecular Sciences|September 29, 2011
Identification and Role of Regulatory Non-Coding RNAs in Listeria monocytogenesBenjamin Izar, Mobarak Abu Mraheil, Torsten Hain
Cancer Journal (Sudbury, Mass.)|January 24, 2017
Clinical Trial Design and Endpoints for Stage IV Melanoma in the Modern EraBenjamin Izar, Meredith M Regan, David F McDermott
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 22, 2020
Beyond Tumor PD-L1: Emerging Genomic Biomarkers for Checkpoint Inhibitor ImmunotherapyGalina G Lagos, Benjamin Izar, Naiyer A Rizvi
Melanoma Research|October 22, 2019
Rapid evolution of acute kidney injury after initial infusion of pembrolizumab in a melanoma patient concurrently treated with RAF/MEK inhibitorsRohit Thummalapalli, Johannes C Melms, James Mier, et al.
Genes and Immunity|December 11, 2023
From patient tissue correlates to molecular mechanisms of cancer immune evasion: the emerging role of CD58 and PD-L1 co-regulation via CMTM6Johannes C Melms, Patricia Ho, Meri Rogava, et al.
Methods in Cell Biology|February 13, 2026
Large-scale CRISPR-Cas9 screens to define regulators of immune checkpointsMichael Mu, Johannes C Melms, Patricia Ho, et al.
Plos One|October 4, 2011
Comparison of devices used for stent-assisted coiling of intracranial aneurysmsBenjamin Izar, Ansaar Rai, Karthikram Raghuram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Predictable Clinical Benefits without Evidence of Synergy in Trials of Combination Therapies with Immune-Checkpoint InhibitorsAdam C Palmer, Benjamin Izar, Haeun Hwangbo, et al.
Pageof 12